A retrospective evaluation of second‐line chemotherapy response in hormone‐refractory prostate carcinoma
Rosenberg J, Galsky M, Rohs N, Weinberg V, Oh W, Kelly W, Small E. A retrospective evaluation of second‐line chemotherapy response in hormone‐refractory prostate carcinoma. Cancer 2005, 106: 58-62. PMID: 16329138, DOI: 10.1002/cncr.21559.Peer-Reviewed Original ResearchConceptsHormone-refractory prostate carcinomaProstate-specific antigenPSA decline >Clinical cross-resistanceTaxane chemotherapyProstate carcinomaProstate-specific antigen declines >PSA responseResponse to second-lineTime to PSA progressionRandomized phase II trialTaxane-resistant cell linesTaxane-based therapyFirst-line therapyKaplan-Meier methodIxabepilone treatmentPSA declinePSA progressionTaxane therapyMedian survivalSecond-lineChemotherapy responseIxabepiloneDisease progressionRetrospective evaluation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply